HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.

AuthorsM G Tektonidou, F N Skopouli
JournalClinical and experimental rheumatology (Clin Exp Rheumatol) 2006 Mar-Apr Vol. 24 Issue 2 Suppl 41 Pg. S103 ISSN: 0392-856X [Print] Italy
PMID16859607 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab
Topics
  • Adult
  • Antibodies, Antineutrophil Cytoplasmic (analysis)
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Granulomatosis with Polyangiitis (complications, drug therapy, immunology)
  • Humans
  • Immunologic Factors (therapeutic use)
  • Remission Induction
  • Rituximab
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: